BAX - Baxter International Inc.

NYSE - NYSE Delayed Price. Currency in USD
82.41
+0.37 (+0.45%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close82.04
Open82.17
Bid82.66 x 800
Ask82.69 x 900
Day's Range81.21 - 82.71
52 Week Range61.05 - 82.80
Volume3,488,140
Avg. Volume2,682,307
Market Cap42.043B
Beta (3Y Monthly)1.07
PE Ratio (TTM)28.11
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.88 (1.07%)
Ex-Dividend Date2019-06-06
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • Business Wire7 days ago

    Baxter Highlights Renal Care Data about Patients’ Health-Related, Quality of Life Outcomes at the 56th ERA-EDTA Congress

    Baxter International Inc. (BAX), a global innovator in renal care, showcased 19 data presentations on therapy options at the 56th ERA-EDTA Congress, Budapest, Hungary, June 13-16. The presentations spanned the renal care continuum, from chronic kidney disease (CKD) management to peritoneal dialysis (PD) and hemodialysis (HD).

  • Business Wire10 days ago

    Baxter Leads Hemodialysis Research Consortium for German Federal Ministry of Education and Research

    Baxter International Inc. (BAX), a global innovator in renal care, today announced receipt of a major research and development (R&D) grant from the German Federal Ministry of Education and Research (BMBF)’s “From Material to Innovation” program to lead a consortium investigating an anticoagulation-free hemodialysis (HD) option for end-stage renal disease (ESRD) patients. The grant provides €1.5 million in funding over three years to Baxter’s research team in Hechingen, Germany, and the consortium partners to find a solution that will improve health-related, quality-of-life outcomes for the millions of patients receiving HD therapy globally.

  • Business Wire13 days ago

    Baxter to Host Second Quarter 2019 Financial Results Conference Call for Investors

    Baxter International Inc. (BAX), a leading global medical products company, will host a conference call to discuss its second quarter 2019 financial results on Thursday, July 25, 2019, at 7:30 a.m. Central Time. The Conference ID is 2089733.

  • Baxter Launches Sharesource 2.0 Telehealth Platform to Support Greater Clinical Insights and Personalized Peritoneal Dialysis Care
    Business Wire13 days ago

    Baxter Launches Sharesource 2.0 Telehealth Platform to Support Greater Clinical Insights and Personalized Peritoneal Dialysis Care

    DEERFIELD, Ill.-- -- Enhancements designed to give healthcare providers access to more comprehensive treatment data and improve clinic workflow New study further supports value of remote patient management technology to personalize dialysis treatments, reduce alarms and in-person visits, while saving clinicians and patients significant time Baxter International Inc. , a global innovator in renal care, ...

  • Business Wire20 days ago

    The Baxter International Foundation Commits $2 Million+ to Operation Smile Care Centers in India

    The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (BAX), announced today a $2.2 million grant to Operation Smile, one of the world’s largest volunteer-based surgical nonprofit organizations, to deliver free surgical and multidisciplinary care to underserved communities in India. During the next three years, the grant will support Operation Smile’s year-round care centers in Mumbai, Srinagar and Bangalore—operated in partnership with the Inga Health Foundation—along with a new care center in Durgapur, West Bengal.

  • Business Wire27 days ago

    Baxter Announces New Research on 3-in-1 Oxiris Set for CRRT and Sepsis Management

    Baxter International Inc. (BAX), a global leader in acute care therapies, announced today that the peer-reviewed journal Blood Purification published a supplemental issue sponsored by Baxter that features real-world clinical experience with the company’s Oxiris filter, which can be used simultaneously in continuous renal replacement therapy (CRRT) and in the removal of cytokines and endotoxin to aide in the management of acute kidney injury (AKI) patients with sepsis. The studies, which are being highlighted at the 37th Vicenza Course on AKI and CRRT in Italy this week, add to the body of scientific knowledge around the use of extracorporeal (outside the body) blood purification (EBP) to address critical conditions.

  • Business Wire2 months ago

    Baxter to Conduct Fixed Income Investor Presentations

    Baxter International Inc. (BAX), a leading global medical products company, today announced that representatives of the company will conduct a series of Fixed Income Investor Presentations on Thursday, May 9, 2019.

  • Business Wire2 months ago

    Baxter Named a “Best Company for Multicultural Women” by Working Mother

    Baxter International Inc. (BAX), a leading global medical products company, announced today that it has been named a 2019 Best Company for Multicultural Women by Working Mother magazine. This recognition is a result of the company’s sustained focus on supporting and advancing multicultural women at all levels of the organization globally.

  • Business Wire2 months ago

    Baxter Increases Dividend and Declares Quarterly Dividend

    Baxter International Inc. , a leading global medical products company, today announced an increase in the company’s quarterly cash dividend, to a rate of $0.22 per share of common stock.

  • Business Wire2 months ago

    Baxter to Present at the UBS Global Healthcare Conference

    Baxter International Inc. (BAX), a leading global medical products company, will present at the UBS Global Healthcare Conference on Monday, May 20, 2019 in New York. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time.

  • Business Wire2 months ago

    Baxter, NAACP and the Alliance for Home Dialysis Expand Program to Increase Awareness of Kidney Care among African Americans

    Baxter International Inc. (BAX), a global leader in renal care, along with the National Association for the Advancement of Colored People (NAACP) and the Alliance for Home Dialysis, today announced that the Dialysis Health Imperative for Access, Choice, and Equity (ACE) program will be expanded for a third year. This year, the program is expected to reach even more individuals and focus on driving awareness of kidney disease—including risk factors, prevention strategies and home dialysis treatment options—among the African American community.

  • Business Wire2 months ago

    Baxter Reports First-Quarter 2019 Results

    DEERFIELD, Ill.-- -- First-quarter revenue of $2.6 billion declined 2 percent on a reported basis and increased 2 percent on an operational basis First-quarter GAAP earnings per share of $0.66; Adjusted EPS of $0.76 increased 9 percent Company now expects full-year 2019 Adjusted EPS of $3.27 to $3.35 1 Baxter International Inc. , a leading global medical products company, today reported results for ...

  • Business Wire2 months ago

    Baxter to Present at the Bank of America Merrill Lynch Health Care Conference 2019

    Baxter International Inc. (BAX), a leading global medical products company, will present at the 2019 Bank of America Merrill Lynch Health Care Conference in Las Vegas on May 15, 2019. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 8:40 a.m. Pacific Time. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

  • Business Wire2 months ago

    Baxter Unveils the Latest Evolution of Floseal at AORN Meeting

    Baxter International Inc. (BAX), a global leader in advancing surgical innovation, today announced that it has received U.S. Food and Drug Administration (FDA) approval for faster preparation of its leading hemostatic product, Floseal Hemostatic Matrix, at the 2019 Association of periOperative Registered Nurses (AORN) Global Surgical Conference and Expo. This next generation of Floseal has 20 percent fewer components and steps to prepare,1 making it easier and faster for operating room (OR) nurses to get Floseal in the hands of surgeons to help stop bleeding during procedures. The new design will be on display at Baxter’s AORN booth #1624.

  • Business Wire3 months ago

    Baxter to Host Webcast of Annual Meeting of Stockholders

    Baxter International Inc. (BAX), a leading global medical products company, will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 7, 2019 at 9 a.m. Central Daylight Time. The live webcast of Baxter’s presentation along with the accompanying slides will be accessible from Baxter’s website at www.baxter.com.

  • Business Wire3 months ago

    Baxter Highlights Advancements in Clinical Nutrition at ASPEN Conference

    Reinforces the company’s efforts to innovate nutrition formulations and delivery mechanisms to meet the needs of patients

  • Business Wire3 months ago

    Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury

    Baxter International Inc. (BAX), a global leader in acute care, and bioMérieux, a world leader in the field of in vitro diagnostics, announced an agreement to develop future biomarkers with the goal to rapidly identify and inform treatment of acute kidney injury (AKI). The announcement was made at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) this week.

  • Business Wire4 months ago

    Baxter Announces U.S. FDA Approval and Launch of Ready-to-Use Cardiovascular Medicine Eptifibatide

    Baxter International Inc. (BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) approval and launch of ready-to-use eptifibatide. Baxter’s presentation of eptifibatide is the first of its kind available in a flexible container.

  • GlobeNewswire4 months ago

    Analysis: Positioning to Benefit within XPO Logistics, L3 Technologies, Domino's Pizza, Baxter International, Conduent, and Xylem — Research Highlights Growth, Revenue, and Consolidated Results

    NEW YORK, March 06, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • Business Wire4 months ago

    Baxter Honored as a 2019 “Top Company for Executive Women” by the National Association for Female Executives

    Baxter International Inc. (BAX), a leading global medical products company, announced today that it has been named one of the 2019 NAFE Top Companies for Executive Women by the National Association for Female Executives (NAFE). This recognition highlights the company’s efforts to advance women in leadership and foster an inclusive and diverse culture.

  • Business Wire4 months ago

    Baxter Declares Quarterly Dividend

    Baxter International Inc. (BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock. The indicated annual dividend rate is $0.76 per share of common stock. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

  • Business Wire4 months ago

    Baxter to Present at the Barclays Global Healthcare Conference

    Baxter International Inc. , a leading global medical products company, will present at the Barclays Global Healthcare Conference in Miami, Fla. on March 12, 2019. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 3:20 p.m.

  • Baxter and NantHealth® Advance Digital Health Technology for Medical Devices in the Hospital ICU
    Business Wire4 months ago

    Baxter and NantHealth® Advance Digital Health Technology for Medical Devices in the Hospital ICU

    @baxter_intl and @NantHealth advance DigitalHealth technology for medical devices in the hospital ICU #CriticalCare #HIMSS19

  • Business Wire5 months ago

    Baxter to Present at the Raymond James 40th Annual Institutional Investors Conference

    Baxter International Inc. , a leading global medical products company, will present at the Raymond James 40th Annual Institutional Investors Conference in Orlando, Fla. on Tuesday, March 5, 2019.

  • GlobeNewswire5 months ago

    Report: Developing Opportunities within Ensco plc, Third Point Reinsurance, Baxter International, Ultrapar Participacoes S.A, Endeavour Silver, and Ingles Markets — Future Expectations, Projections Moving into 2019

    NEW YORK, Feb. 04, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.